Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Biologics & Biosimilars market report explains the definition, types, applications, major countries, and major players of the Biologics & Biosimilars market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
CP Guojian Pharmacy
Johnson & Johnson
Biotech Pharma
fizer
Roche
AbbVie
3sbio
Sanofi
Mylan
Merck
Sandoz
Teva
Gelgen Biopharma
Amgen
Lilly
Changchun High Tech
Novo Nordisk
Hospira
Novartis
By Type:
Antibiotic
Enzyme
Hormone
Non-Patented Biological Reagents
Other
By End-User:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Biologics & Biosimilars Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Biologics & Biosimilars Outlook to 2028- Original Forecasts
-
2.2 Biologics & Biosimilars Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Biologics & Biosimilars Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Biologics & Biosimilars Market- Recent Developments
-
6.1 Biologics & Biosimilars Market News and Developments
-
6.2 Biologics & Biosimilars Market Deals Landscape
7 Biologics & Biosimilars Raw Materials and Cost Structure Analysis
-
7.1 Biologics & Biosimilars Key Raw Materials
-
7.2 Biologics & Biosimilars Price Trend of Key Raw Materials
-
7.3 Biologics & Biosimilars Key Suppliers of Raw Materials
-
7.4 Biologics & Biosimilars Market Concentration Rate of Raw Materials
-
7.5 Biologics & Biosimilars Cost Structure Analysis
-
7.5.1 Biologics & Biosimilars Raw Materials Analysis
-
7.5.2 Biologics & Biosimilars Labor Cost Analysis
-
7.5.3 Biologics & Biosimilars Manufacturing Expenses Analysis
8 Global Biologics & Biosimilars Import and Export Analysis (Top 10 Countries)
-
8.1 Global Biologics & Biosimilars Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Biologics & Biosimilars Export by Region (Top 10 Countries) (2017-2028)
9 Global Biologics & Biosimilars Market Outlook by Types and Applications to 2022
-
9.1 Global Biologics & Biosimilars Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antibiotic Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Enzyme Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Hormone Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Non-Patented Biological Reagents Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Biologics & Biosimilars Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Tumor Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Cardiovascular Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Hemophilia Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Biologics & Biosimilars Market Analysis and Outlook till 2022
-
10.1 Global Biologics & Biosimilars Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Biologics & Biosimilars Consumption (2017-2022)
-
10.2.2 Canada Biologics & Biosimilars Consumption (2017-2022)
-
10.2.3 Mexico Biologics & Biosimilars Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Biologics & Biosimilars Consumption (2017-2022)
-
10.3.2 UK Biologics & Biosimilars Consumption (2017-2022)
-
10.3.3 Spain Biologics & Biosimilars Consumption (2017-2022)
-
10.3.4 Belgium Biologics & Biosimilars Consumption (2017-2022)
-
10.3.5 France Biologics & Biosimilars Consumption (2017-2022)
-
10.3.6 Italy Biologics & Biosimilars Consumption (2017-2022)
-
10.3.7 Denmark Biologics & Biosimilars Consumption (2017-2022)
-
10.3.8 Finland Biologics & Biosimilars Consumption (2017-2022)
-
10.3.9 Norway Biologics & Biosimilars Consumption (2017-2022)
-
10.3.10 Sweden Biologics & Biosimilars Consumption (2017-2022)
-
10.3.11 Poland Biologics & Biosimilars Consumption (2017-2022)
-
10.3.12 Russia Biologics & Biosimilars Consumption (2017-2022)
-
10.3.13 Turkey Biologics & Biosimilars Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Biologics & Biosimilars Consumption (2017-2022)
-
10.4.2 Japan Biologics & Biosimilars Consumption (2017-2022)
-
10.4.3 India Biologics & Biosimilars Consumption (2017-2022)
-
10.4.4 South Korea Biologics & Biosimilars Consumption (2017-2022)
-
10.4.5 Pakistan Biologics & Biosimilars Consumption (2017-2022)
-
10.4.6 Bangladesh Biologics & Biosimilars Consumption (2017-2022)
-
10.4.7 Indonesia Biologics & Biosimilars Consumption (2017-2022)
-
10.4.8 Thailand Biologics & Biosimilars Consumption (2017-2022)
-
10.4.9 Singapore Biologics & Biosimilars Consumption (2017-2022)
-
10.4.10 Malaysia Biologics & Biosimilars Consumption (2017-2022)
-
10.4.11 Philippines Biologics & Biosimilars Consumption (2017-2022)
-
10.4.12 Vietnam Biologics & Biosimilars Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Biologics & Biosimilars Consumption (2017-2022)
-
10.5.2 Colombia Biologics & Biosimilars Consumption (2017-2022)
-
10.5.3 Chile Biologics & Biosimilars Consumption (2017-2022)
-
10.5.4 Argentina Biologics & Biosimilars Consumption (2017-2022)
-
10.5.5 Venezuela Biologics & Biosimilars Consumption (2017-2022)
-
10.5.6 Peru Biologics & Biosimilars Consumption (2017-2022)
-
10.5.7 Puerto Rico Biologics & Biosimilars Consumption (2017-2022)
-
10.5.8 Ecuador Biologics & Biosimilars Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Biologics & Biosimilars Consumption (2017-2022)
-
10.6.2 Kuwait Biologics & Biosimilars Consumption (2017-2022)
-
10.6.3 Oman Biologics & Biosimilars Consumption (2017-2022)
-
10.6.4 Qatar Biologics & Biosimilars Consumption (2017-2022)
-
10.6.5 Saudi Arabia Biologics & Biosimilars Consumption (2017-2022)
-
10.6.6 United Arab Emirates Biologics & Biosimilars Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Biologics & Biosimilars Consumption (2017-2022)
-
10.7.2 South Africa Biologics & Biosimilars Consumption (2017-2022)
-
10.7.3 Egypt Biologics & Biosimilars Consumption (2017-2022)
-
10.7.4 Algeria Biologics & Biosimilars Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Biologics & Biosimilars Consumption (2017-2022)
-
10.8.2 New Zealand Biologics & Biosimilars Consumption (2017-2022)
11 Global Biologics & Biosimilars Competitive Analysis
-
11.1 CP Guojian Pharmacy
-
11.1.1 CP Guojian Pharmacy Company Details
-
11.1.2 CP Guojian Pharmacy Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 CP Guojian Pharmacy Biologics & Biosimilars Main Business and Markets Served
-
11.1.4 CP Guojian Pharmacy Biologics & Biosimilars Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Johnson & Johnson
-
11.2.1 Johnson & Johnson Company Details
-
11.2.2 Johnson & Johnson Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Johnson & Johnson Biologics & Biosimilars Main Business and Markets Served
-
11.2.4 Johnson & Johnson Biologics & Biosimilars Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Biotech Pharma
-
11.3.1 Biotech Pharma Company Details
-
11.3.2 Biotech Pharma Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Biotech Pharma Biologics & Biosimilars Main Business and Markets Served
-
11.3.4 Biotech Pharma Biologics & Biosimilars Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 fizer
-
11.4.1 fizer Company Details
-
11.4.2 fizer Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 fizer Biologics & Biosimilars Main Business and Markets Served
-
11.4.4 fizer Biologics & Biosimilars Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Roche
-
11.5.1 Roche Company Details
-
11.5.2 Roche Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Roche Biologics & Biosimilars Main Business and Markets Served
-
11.5.4 Roche Biologics & Biosimilars Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 AbbVie
-
11.6.1 AbbVie Company Details
-
11.6.2 AbbVie Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 AbbVie Biologics & Biosimilars Main Business and Markets Served
-
11.6.4 AbbVie Biologics & Biosimilars Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 3sbio
-
11.7.1 3sbio Company Details
-
11.7.2 3sbio Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 3sbio Biologics & Biosimilars Main Business and Markets Served
-
11.7.4 3sbio Biologics & Biosimilars Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Sanofi
-
11.8.1 Sanofi Company Details
-
11.8.2 Sanofi Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Sanofi Biologics & Biosimilars Main Business and Markets Served
-
11.8.4 Sanofi Biologics & Biosimilars Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Mylan
-
11.9.1 Mylan Company Details
-
11.9.2 Mylan Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Mylan Biologics & Biosimilars Main Business and Markets Served
-
11.9.4 Mylan Biologics & Biosimilars Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Merck
-
11.10.1 Merck Company Details
-
11.10.2 Merck Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Merck Biologics & Biosimilars Main Business and Markets Served
-
11.10.4 Merck Biologics & Biosimilars Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Sandoz
-
11.11.1 Sandoz Company Details
-
11.11.2 Sandoz Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Sandoz Biologics & Biosimilars Main Business and Markets Served
-
11.11.4 Sandoz Biologics & Biosimilars Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Teva
-
11.12.1 Teva Company Details
-
11.12.2 Teva Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Teva Biologics & Biosimilars Main Business and Markets Served
-
11.12.4 Teva Biologics & Biosimilars Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Gelgen Biopharma
-
11.13.1 Gelgen Biopharma Company Details
-
11.13.2 Gelgen Biopharma Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Gelgen Biopharma Biologics & Biosimilars Main Business and Markets Served
-
11.13.4 Gelgen Biopharma Biologics & Biosimilars Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Amgen
-
11.14.1 Amgen Company Details
-
11.14.2 Amgen Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Amgen Biologics & Biosimilars Main Business and Markets Served
-
11.14.4 Amgen Biologics & Biosimilars Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Lilly
-
11.15.1 Lilly Company Details
-
11.15.2 Lilly Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Lilly Biologics & Biosimilars Main Business and Markets Served
-
11.15.4 Lilly Biologics & Biosimilars Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Changchun High Tech
-
11.16.1 Changchun High Tech Company Details
-
11.16.2 Changchun High Tech Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Changchun High Tech Biologics & Biosimilars Main Business and Markets Served
-
11.16.4 Changchun High Tech Biologics & Biosimilars Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Novo Nordisk
-
11.17.1 Novo Nordisk Company Details
-
11.17.2 Novo Nordisk Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Novo Nordisk Biologics & Biosimilars Main Business and Markets Served
-
11.17.4 Novo Nordisk Biologics & Biosimilars Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Hospira
-
11.18.1 Hospira Company Details
-
11.18.2 Hospira Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Hospira Biologics & Biosimilars Main Business and Markets Served
-
11.18.4 Hospira Biologics & Biosimilars Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Novartis
-
11.19.1 Novartis Company Details
-
11.19.2 Novartis Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Novartis Biologics & Biosimilars Main Business and Markets Served
-
11.19.4 Novartis Biologics & Biosimilars Product Portfolio
-
11.19.5 Recent Research and Development Strategies
12 Global Biologics & Biosimilars Market Outlook by Types and Applications to 2028
-
12.1 Global Biologics & Biosimilars Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Antibiotic Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Enzyme Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Hormone Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Non-Patented Biological Reagents Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Biologics & Biosimilars Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Tumor Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Biologics & Biosimilars Market Analysis and Outlook to 2028
-
13.1 Global Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.2.2 Canada Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.2.3 Mexico Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.3.2 UK Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.3.3 Spain Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.3.4 Belgium Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.3.5 France Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.3.6 Italy Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.3.7 Denmark Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.3.8 Finland Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.3.9 Norway Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.3.10 Sweden Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.3.11 Poland Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.3.12 Russia Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.3.13 Turkey Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.4.2 Japan Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.4.3 India Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.4.4 South Korea Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.4.8 Thailand Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.4.9 Singapore Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.4.11 Philippines Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.5.2 Colombia Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.5.3 Chile Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.5.4 Argentina Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.5.6 Peru Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.6.3 Oman Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.6.4 Qatar Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.7.2 South Africa Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.7.3 Egypt Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.7.4 Algeria Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Biologics & Biosimilars Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Biologics & Biosimilars Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Biologics & Biosimilars
-
Figure of Biologics & Biosimilars Picture
-
Table Global Biologics & Biosimilars Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Biologics & Biosimilars Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Antibiotic Consumption and Growth Rate (2017-2022)
-
Figure Global Enzyme Consumption and Growth Rate (2017-2022)
-
Figure Global Hormone Consumption and Growth Rate (2017-2022)
-
Figure Global Non-Patented Biological Reagents Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Tumor Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Consumption and Growth Rate (2017-2022)
-
Figure Global Hemophilia Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Biologics & Biosimilars Consumption by Country (2017-2022)
-
Table North America Biologics & Biosimilars Consumption by Country (2017-2022)
-
Figure United States Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Canada Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Mexico Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Table Europe Biologics & Biosimilars Consumption by Country (2017-2022)
-
Figure Germany Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure UK Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Spain Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Belgium Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure France Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Italy Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Denmark Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Finland Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Norway Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Sweden Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Poland Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Russia Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Turkey Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Table APAC Biologics & Biosimilars Consumption by Country (2017-2022)
-
Figure China Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Japan Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure India Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure South Korea Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Thailand Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Singapore Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Philippines Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Table South America Biologics & Biosimilars Consumption by Country (2017-2022)
-
Figure Brazil Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Colombia Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Chile Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Argentina Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Peru Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Table GCC Biologics & Biosimilars Consumption by Country (2017-2022)
-
Figure Bahrain Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Oman Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Qatar Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Table Africa Biologics & Biosimilars Consumption by Country (2017-2022)
-
Figure Nigeria Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure South Africa Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Egypt Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure Algeria Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Table Oceania Biologics & Biosimilars Consumption by Country (2017-2022)
-
Figure Australia Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Biologics & Biosimilars Consumption and Growth Rate (2017-2022)
-
Table CP Guojian Pharmacy Company Details
-
Table CP Guojian Pharmacy Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table CP Guojian Pharmacy Biologics & Biosimilars Main Business and Markets Served
-
Table CP Guojian Pharmacy Biologics & Biosimilars Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Biologics & Biosimilars Main Business and Markets Served
-
Table Johnson & Johnson Biologics & Biosimilars Product Portfolio
-
Table Biotech Pharma Company Details
-
Table Biotech Pharma Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biotech Pharma Biologics & Biosimilars Main Business and Markets Served
-
Table Biotech Pharma Biologics & Biosimilars Product Portfolio
-
Table fizer Company Details
-
Table fizer Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table fizer Biologics & Biosimilars Main Business and Markets Served
-
Table fizer Biologics & Biosimilars Product Portfolio
-
Table Roche Company Details
-
Table Roche Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Biologics & Biosimilars Main Business and Markets Served
-
Table Roche Biologics & Biosimilars Product Portfolio
-
Table AbbVie Company Details
-
Table AbbVie Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Biologics & Biosimilars Main Business and Markets Served
-
Table AbbVie Biologics & Biosimilars Product Portfolio
-
Table 3sbio Company Details
-
Table 3sbio Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table 3sbio Biologics & Biosimilars Main Business and Markets Served
-
Table 3sbio Biologics & Biosimilars Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Biologics & Biosimilars Main Business and Markets Served
-
Table Sanofi Biologics & Biosimilars Product Portfolio
-
Table Mylan Company Details
-
Table Mylan Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Biologics & Biosimilars Main Business and Markets Served
-
Table Mylan Biologics & Biosimilars Product Portfolio
-
Table Merck Company Details
-
Table Merck Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Biologics & Biosimilars Main Business and Markets Served
-
Table Merck Biologics & Biosimilars Product Portfolio
-
Table Sandoz Company Details
-
Table Sandoz Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sandoz Biologics & Biosimilars Main Business and Markets Served
-
Table Sandoz Biologics & Biosimilars Product Portfolio
-
Table Teva Company Details
-
Table Teva Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Biologics & Biosimilars Main Business and Markets Served
-
Table Teva Biologics & Biosimilars Product Portfolio
-
Table Gelgen Biopharma Company Details
-
Table Gelgen Biopharma Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gelgen Biopharma Biologics & Biosimilars Main Business and Markets Served
-
Table Gelgen Biopharma Biologics & Biosimilars Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Biologics & Biosimilars Main Business and Markets Served
-
Table Amgen Biologics & Biosimilars Product Portfolio
-
Table Lilly Company Details
-
Table Lilly Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lilly Biologics & Biosimilars Main Business and Markets Served
-
Table Lilly Biologics & Biosimilars Product Portfolio
-
Table Changchun High Tech Company Details
-
Table Changchun High Tech Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Changchun High Tech Biologics & Biosimilars Main Business and Markets Served
-
Table Changchun High Tech Biologics & Biosimilars Product Portfolio
-
Table Novo Nordisk Company Details
-
Table Novo Nordisk Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Biologics & Biosimilars Main Business and Markets Served
-
Table Novo Nordisk Biologics & Biosimilars Product Portfolio
-
Table Hospira Company Details
-
Table Hospira Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hospira Biologics & Biosimilars Main Business and Markets Served
-
Table Hospira Biologics & Biosimilars Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Biologics & Biosimilars Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Biologics & Biosimilars Main Business and Markets Served
-
Table Novartis Biologics & Biosimilars Product Portfolio
-
Figure Global Antibiotic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enzyme Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-Patented Biological Reagents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biologics & Biosimilars Consumption Forecast by Country (2022-2028)
-
Table North America Biologics & Biosimilars Consumption Forecast by Country (2022-2028)
-
Figure United States Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Biologics & Biosimilars Consumption Forecast by Country (2022-2028)
-
Figure Germany Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Biologics & Biosimilars Consumption Forecast by Country (2022-2028)
-
Figure China Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Biologics & Biosimilars Consumption Forecast by Country (2022-2028)
-
Figure Brazil Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Biologics & Biosimilars Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Biologics & Biosimilars Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Biologics & Biosimilars Consumption Forecast by Country (2022-2028)
-
Figure Australia Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Biologics & Biosimilars Consumption Forecast and Growth Rate (2022-2028)
-
